# Control-IQ Technology in Individuals With Type 2 Diabetes

> **NCT05111301** · NA · COMPLETED · sponsor: **Tandem Diabetes Care, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** Control-IQ technology 1.5

## Key facts

- **NCT ID:** NCT05111301
- **Lead sponsor:** Tandem Diabetes Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2022-08-10
- **Final completion:** 2022-08-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111301, "Control-IQ Technology in Individuals With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05111301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*